Terms: = Breast cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Staging
9 results:
1. The efficacy of abbreviated breast MRI protocols using 1.5 T MRI in the preoperative staging of newly diagnosed breast cancers.
Kadioglu ME; Metin Y; Metin NO; Tasci F; Ozdemir O; Kupeli A
Clin Imaging; 2023 Sep; 101():44-49. PubMed ID: 37295233
[TBL] [Abstract] [Full Text] [Related]
2. Radiomics model based on shear-wave elastography in the assessment of axillary lymph node status in early-stage breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Chen RX; Tang SC; Lv WZ; Cui XW; Dietrich CF
Eur Radiol; 2022 Apr; 32(4):2313-2325. PubMed ID: 34671832
[TBL] [Abstract] [Full Text] [Related]
3. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
[TBL] [Abstract] [Full Text] [Related]
4. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract] [Full Text] [Related]
5. BEX2 promotes tumor proliferation in colorectal cancer.
Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
[TBL] [Abstract] [Full Text] [Related]
6. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
[TBL] [Abstract] [Full Text] [Related]
7. breast MRI and 18F FDG PET/CT in the management of breast cancer.
Iagaru A; Masamed R; Keesara S; Conti PS
Ann Nucl Med; 2007 Jan; 21(1):33-8. PubMed ID: 17373334
[TBL] [Abstract] [Full Text] [Related]
8. Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors.
Bamberger AM; Milde-Langosch K; Schulte HM; Löning T
Horm Res; 2000; 54(1):32-7. PubMed ID: 11182633
[TBL] [Abstract] [Full Text] [Related]
9. Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.
Bamberger AM; Methner C; Lisboa BW; Städtler C; Schulte HM; Löning T; Milde-Langosch K
Int J Cancer; 1999 Oct; 84(5):533-8. PubMed ID: 10502734
[TBL] [Abstract] [Full Text] [Related]
